Impact of clinical trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0

Sites Throughout LATAM

+ 200

Patients in our network

+ 0

Conducted Studies

0 %

Lost-to-Follow Up rate

As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Impact of clinical trials in Brazil

Impact of clinical trials in Brazil – Clinical Trial South America

Clinical trials play a crucial role in advancing medical knowledge, improving patient care, and promoting medical innovation. In recent years, Brazil has emerged as a prominent destination for clinical research, offering significant benefits to both participants and the country’s healthcare system.

This article explores the impact of clinical trials in Brazil, highlighting their contributions to medical advancements, patient access to innovative treatments, economic growth, and regulatory development.

Advancing Medical Knowledge

Clinical trials in Brazil have significantly contributed to expanding our understanding of various diseases, evaluating new treatments, and assessing the safety and efficacy of pharmaceuticals and medical devices. These trials provide a platform for researchers to investigate prevalent health conditions in the country, such as infectious diseases, cardiovascular disorders, cancer, and neurological conditions.

By conducting clinical trials within Brazil, researchers gain valuable insights into treatment effectiveness and safety within the local population. This facilitates the development of tailored interventions, leading to improved patient outcomes and reducing reliance on data extrapolated from trials conducted in other regions.

Improved Access to Innovative Treatments

Participating in clinical trials grants Brazilian patients access to cutting-edge treatments that may not yet be available through standard care. This offers new hope to individuals with limited treatment options or those who have exhausted traditional therapies.

By facilitating participation in clinical trials, Brazil ensures that its citizens have access to potentially life-saving or life-changing interventions that would otherwise be out of reach.

Additionally, successful clinical trials contribute to the development of new drugs and medical devices. Regulatory approvals resulting from these trials allow innovative treatments to enter the market, benefiting patients nationwide. This fosters a culture of medical innovation in Brazil’s healthcare system, driving progress and ensuring patients have access to the latest therapies.

Impact of clinical trials in Brazil

Impact of clinical trials in Brazil

Economic Growth and Job Creation

Clinical trials have a positive impact on Brazil’s economy by attracting investments from pharmaceutical companies, contract research organizations (CROs), and academic institutions. These investments support the development of research infrastructure, the purchase of equipment, and the employment of highly skilled professionals.

Clinical trials require a diverse range of expertise, including physicians, nurses, research coordinators, and data managers, creating job opportunities and expanding the healthcare workforce.

Moreover, hosting clinical trials enhances Brazil’s reputation as a destination for clinical research, attracting foreign investments and collaborations. This results in knowledge transfer, technology exchange, and long-term growth for the healthcare sector, contributing to the country’s economic development and fostering scientific excellence.

Regulatory Development and Patient Safety

The increase in clinical trials in Brazil has prompted the development and strengthening of regulatory frameworks to ensure patient safety and research integrity. Government agencies, such as the Brazilian Health Regulatory Agency (ANVISA), have implemented rigorous regulations and guidelines to uphold ethical standards and international best practices.

The establishment of robust regulatory processes safeguards the rights and welfare of trial participants, instilling transparency and trust among the public. By fostering a culture of ethical research, Brazil demonstrates its commitment to upholding high standards in clinical trials, attracting further investment and collaborations.

Conclusion

Clinical trials in Brazil have a profound impact on healthcare, research, and the economy. They contribute to medical advancements, provide patients with access to innovative treatments, drive economic growth, and foster regulatory development. By embracing clinical research, Brazil positions itself as a significant contributor to global medical innovation, ultimately improving patient outcomes and promoting the well-being of its population.

Impact of clinical trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Impact of clinical trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.

Impact of clinical trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Impact of clinical trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Impact of clinical trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

Site Management

Data Management

Site Selection

Regulatory Submissions

Clinical Monitoring

Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

First-in-human studies

Medical Devices

Pilot and Pivotal Device Studies

Phases I – III

We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

Diabetes/Metabolic Syndromes
Infectious Diseases
Cardiovascular
Neurology
Respiratory
Oncology

Impact of clinical trials in Brazil

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

We offer the quickest start-up times in each country.
Efficient Clinical Site Selection and Contracting.
Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

Proven record of delivering rescue studies, we consistently exceed industry performance standards.
Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
At Cohortias, we prioritize short lines of communication to ensure efficient collaboration.
Swift adaptation to changes in the trial landscape to keep your study on schedule.

Impact of clinical trials in Brazil

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Impact of clinical trials in Brazil

The Cohortias Team

Impact of clinical trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Impact of clinical trials in Brazil

Network & Partnerships

CROs alliance of Mexico

Health System of Tec de Monterrey

The Science CRO of Europe